Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 28, 2020

View Archived Issues

Just add fever

Tyme advancing oral synthetic bile acid TYME-19 into clinic for COVID-19

STING agonist JNJ-67544412 shows antitumor activity in syngeneic tumor models

Synthetic synaptic protein restores neuronal connections

CKI-alpha/delta inhibitors disclosed by Bayer, Dana-Farber and The Broad Institute

Novartis discovers deltaF508 mutant CFTR correctors

New neurotensin receptor type 2 agonists patented by Socpra Sciences Sante et Humaines SEC

Medibiofarma identifies new prostanoid EP2 and/or EP4 receptor ligands

ATSO Corp, Cas Biotechnology present antisense oligonucleotides against GST proteins

Interim data from phase I study of 4-1BB antibody ATOR-1017 in advanced cancer

European conditional marketing authorization for Blenrep in relapsed and refractory multiple myeloma

ViiV begins first-in-human study with GSK-3739937 for HIV

Ocellaris opens enrollment in phase Ib/IIa study of OC-001 in locally advanced or metastatic cancers

UCB studies dapirolizumab pegol in phase III for moderate to severely active SLE

PRAK-3202 generates immune response against SARS-Cov-2 antigens in mice

Limited effect on HBsAg seen with JNJ-6379 regimens in phase II HBV study

Lilly begins phase II study of LY-3471851 for SLE

GNE-565: a Nav1.7 inhibitor with oral activity in a mouse model of Nav.17-associated pain

New phase IIa study evaluates AMT-101 in ulcerative colitis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...